The safety of NSAIDs in heart failure patients
Links shared publicly online about this topic.
- 1,126total visits
The safety of NSAIDs in heart failure patients
View full resource at cardiologytoday.com
Tags: Heart, Heart Disease, Heart Failure, NSAIDs, Cardiology
Most Recently Shared on June 28, 2010 at 5:49 pm By:
Safety of NSAIDS in heart failure patients.http://www.cardiologytoday.com/view.aspx?rid=65044
Also Shared By:
Patient and Family Engagement at BIDMC - Beth Israel Deaconess Medical Center
bidmc.org — “Become a BIDMC Patient/Family Advisor and partner with us to help improve the health outcomes for patients throughout the medical center. Your voice could lead to improvements in quality, safety, communication and hospital processes that have a dramatic impact on the patient care experience. For more information, please email your questions and contact information to PFAC@bidmc.harvard.edu.” View full resource at bidmc.org
Most Recently Shared on December 2, 2011 at 3:29 pm By:
Have you had your baby at BIDMC within the past 2 years? Consider becoming a patient advisor. http://t.co/aArOQXyb
Feature: Putting practices in place to curb HF readmissions
cardiovascularbusiness.com — “Despite recent efforts to reduce readmission rates in the U.S., results from a report by the Dartmouth Atlas Project showed a large regional variation in 30-day readmission rates, particularly for Medicare beneficiaries post-acute care. The average readmission rate in the U.S. currently stand at 16.1 percent, which shows that more needs to be done to close gaps in care. To help get a handle on readmissions, providers from Spectrum Health have developed cardiac care solutions for patients to try ” View full resource at cardiovascularbusiness.com
Most Recently Shared on November 17, 2011 at 8:41 pm By:
Spectrum Health Healthcare System
National mag features Spectrum Health's unique quality and safety measures for reducing heart failure readmission rates http://t.co/wBuMSMoS
Press Release Archive: SPAF
boehringer-ingelheim.com — “New RE-LY® sub-analyses demonstrate safety and efficacy of Pradaxa® (dabigatran etexilate) in patients with heart failure & those undergoing surgery” View full resource at boehringer-ingelheim.com
Most Recently Shared on November 14, 2011 at 2:48 pm By:
#AHA11 NEWS: New RE-LY® sub-analyses on safety/efficacy of dabigatran with heart failure & undergoing surgery PRESS: http://t.co/1SoNOM2E
Northwest Medical Center: iPhone, iPad App Supports Patient Safety Following Heart Attacks - GE Healthcare Newsroom
newsroom.gehealthcare.com — “After a heart attack, seconds count. The longer it takes to make a treatment decision, the greater the risks for heart muscle. That’s why Dr. Jose Soler, cardiologist at Northwest Medical Center, says “time is muscle.” Weakened heart muscle limits the patient’s ability to pump blood and may ultimately lead to chronic heart failure. This is a significant health issue—heart failure affects about 5.7 million Americans.1Traditionally, on-call cardiologists rely on EKG d” View full resource at newsroom.gehealthcare.com
Most Recently Shared on November 2, 2011 at 6:15 pm By:
Cameron Powell Surgeon, Health Executive, Physician, Doctor, and ObGyn Physician
AirStrip, GE Healthcare and Northwest Medical Center work together on CARDIOLOGY http://t.co/N9BRks3c
Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure
news-medical.net — “Boston Scientific Corporation has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) clinical trial. NECTAR-HF is a prospective, randomized, international clinical feasibility study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients.” View full resource at news-medical.net
Most Recently Shared on September 30, 2011 at 5:14 am By:
Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure: Boston Scientific Corp... http://t.co/kz1NyORx
The Role of Exercise Training in Heart Failure - QualityPoint Technologies
qualitypointtech.net — “Evidence is strong for the benefits and safety of an exercise training program for the stable, systolic heart failure patient who is receiving optimal medical treatment. Journal of the American College of Cardiology” View full resource at qualitypointtech.net
Most Recently Shared on August 16, 2011 at 11:45 am By:
The Role of Exercise Training in Heart Failure: Evidence is strong for the benefits and safety of an exercise trai... http://t.co/mUqffSm
Are You Delivering on the Promise of Higher Quality? :: Article - The Hospitalist
the-hospitalist.org — “One hospitalist-led pilot project produced a 61 decrease in heart failure readmission rates. Another resulted in a 33 drop in all-cause readmissions. The numbers might be impressive, but what do they really say about how hospitalists have influenced healthcare quality When HM emerged 15 years ago, advocates pitched the fledgling physician...” View full resource at the-hospitalist.org
Most Recently Shared on August 4, 2011 at 2:33 pm By:
Timothy Myers Physician, Doctor, and Radiologist
RT @PatientSafety01: R U Delivering on the Promise of Higher #Quality? Something 2 consider as we "improve" quality. http://bit.ly/o43Iy0
NSAIDs raise risk of heart disease: Study
news-medical.net — “A new study published online in the British Medical Journal explores the relative safety of non-steroidal anti-inflammatory medications (NSAIDs), commonly used to treat joint and muscle aches and pain and concludes that NSAIDs significantly increase the risk of cardiovascular events in patients who take them regularly.” View full resource at news-medical.net
Most Recently Shared on January 13, 2011 at 8:07 am By:
Stroke News: NSAIDs raise risk of heart disease: Study: A new study published online in the British Medical Jo... http://twurl.nl/6w3tf5
AHRQ Patient Safety Network
psnet.ahrq.gov — “AHRQ Patient Safety Network” View full resource at psnet.ahrq.gov
Most Recently Shared on December 20, 2010 at 11:48 pm By:
RT @quality1: Assoc found btwn lower safety culture & higher 30-day readmit rates for AMI & heart failure http://ow.ly/3rW31 #ptsafety
Symposier - Nesiritide for Acute Heart Failure
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews --" Results from the 7,000-patient ASCEND-HF trial show that nesiritide was safe for treating patients with acute decompensated heart failure, but on average it only exerted a small dyspnea. Despite that, nesiritide has a role as a second-line agent because of its safety and ability to help certain patients. Read the story: http://bit.ly/evpUhy” View full resource at symposier.com
Most Recently Shared on December 3, 2010 at 11:48 pm By:
Symposier Cardiology Cardiology and Health Business
Nesiritide for Acute Heart Failure, Results from ASCENT-HF show nesiritide is safe. http://bit.ly/hZkpDY
Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglitazone
news-medical.net — “A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 prin” View full resource at news-medical.net
Most Recently Shared on June 29, 2010 at 11:37 am By:
Medicare News: Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglit... http://bit.ly/d2HJDC
Yearlong collaborative partnership launched to reduce hospital readmissions due to heart failure
news-medical.net — “More than 5 million individuals in the United States suffer from chronic heart failure, making it one of the most common reasons for hospitalizations and readmissions. To address this costly issue, the New Jersey Hospital Association's Institute for Quality and Patient Safety this week launched a yearlong collaborative partnership to reduce hospital readmissions due to heart failure and improve the quality of healthcare in New Jersey.” View full resource at news-medical.net
Most Recently Shared on June 18, 2010 at 9:53 am By:
Yearlong collaborative partnership launched to reduce hospital readmissions due to heart failure: More than 5 mill... http://bit.ly/9S5N74
ARCA biopharma announces SPA agreement with FDA for bucindolol clinical trial
news-medical.net — “ARCA biopharma, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a clinical trial to assess the safety and efficacy of bucindolol in approximately 3,200 patients with chronic heart failure who have the genotype that appears to respond most favorably to bucindolol. Bucindolol is the Company's investigational, pharmacologically unique, beta-blocker and mild vasodilator.” View full resource at news-medical.net
Most Recently Shared on May 17, 2010 at 1:50 pm By:
ARCA biopharma announces SPA agreement with FDA for bucindolol clinical trial: ARCA biopharma, Inc. today announce... http://bit.ly/bKagau
Juventas Therapeutics Enrolling Phase I Clinical Trial Of JVS-100 For Patients With Heart Failure
medicalnewstoday.com — “Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and eff” View full resource at medicalnewstoday.com
Most Recently Shared on April 6, 2010 at 5:11 pm By:
MNT Pharma News Pharma and Health News
Juventas Therapeutics Enrolling Phase I Clinical Trial Of JVS-100 For Patients With Heart Failure http://mnt.to/3zRk #pharma #pharmaceutical
Advertisement
low sodium foods
@HealthyHeart4u
The safety of NSAIDs in heart failure patients - Cardiology Today http://bit.ly/9B3PBU
1 year ago...